Throughout 2025, the team at Liver Disease News has reported on the latest research and advances in care related to…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Researchers in the U.S. have developed a rapid point-of-care test that detects active hepatitis C infection by identifying HCV…
CHOLESTASIS
NewsHeart complications common in children with PFIC, study finds
About half of children with progressive familial intrahepatic cholestasis (PFIC) were found to have cirrhotic cardiomyopathy (CCM), a form…
FATTY LIVER DISEASE
NewsFDA authorizes use of 1st AI tool to speed MASH clinical trials
The U.S. Food and Drug Administration (FDA) has authorized the use of the first artificial intelligence (AI) drug-development tool for…
BILIARY ATRESIA
NewsLess invasive Kasai surgery works better for infants with BA: Study
Using a minimally invasive method called laparoscopy to conduct standard Kasai surgery significantly reduces blood loss and increases the chances…
Major medical associations and state health departments are moving to maintain the standard of universal hepatitis B vaccination at…
CHOLESTASIS
NewsCommon virus may play a role in ICP development, study finds
Infection with human cytomegalovirus (HCMV), a common and usually harmless virus, may play a role in the development of…
FATTY LIVER DISEASE
NewsLower-cost TAEUS device tracks liver fat on par with gold standard
TAEUS, a diagnostic tool being developed by Endra Life Sciences, measures liver fat levels with similar accuracy to gold-standard…
CHOLANGITIS
NewsNebokitug reduces immune cell activity that drives PSC: Data
Nebokitug, an experimental infusion therapy being developed by Chemomab Therapeutics for primary sclerosing…
FATTY LIVER DISEASE
NewsBelapectin may help reduce liver scarring in those with severe MASH
Galectin Therapeutics‘ experimental medication belapectin may help reduce liver scarring, or fibrosis, and lower the risk of blood vessel…